Your browser is no longer supported. Please, upgrade your browser.
Quotient Limited
Index- P/E- EPS (ttm)-1.24 Insider Own0.70% Shs Outstand101.57M Perf Week-5.96%
Market Cap204.71M Forward P/E- EPS next Y-0.92 Insider Trans7.70% Shs Float76.96M Perf Month-9.29%
Income-125.00M PEG- EPS next Q-0.26 Inst Own86.30% Short Float6.48% Perf Quarter-25.99%
Sales36.90M P/S5.55 EPS this Y17.50% Inst Trans-0.23% Short Ratio6.07 Perf Half Y-41.26%
Book/sh-0.84 P/B- EPS next Y12.40% ROA-50.40% Target Price9.38 Perf Year-66.28%
Cash/sh1.42 P/C1.44 EPS next 5Y- ROE286.70% 52W Range1.69 - 6.42 Perf YTD-20.85%
Dividend- P/FCF- EPS past 5Y6.90% ROI-53.70% 52W High-69.00% Beta2.42
Dividend %- Quick Ratio5.00 Sales past 5Y18.60% Gross Margin46.40% 52W Low17.75% ATR0.17
Employees433 Current Ratio5.80 Sales Q/Q-41.00% Oper. Margin- RSI (14)41.61 Volatility6.64% 8.24%
OptionableYes Debt/Eq- EPS Q/Q-62.90% Profit Margin- Rel Volume0.39 Prev Close2.05
ShortableYes LT Debt/Eq- EarningsNov 09 BMO Payout- Avg Volume821.54K Price1.99
Recom1.70 SMA20-11.91% SMA50-9.05% SMA200-35.75% Volume279,766 Change-2.93%
Jun-03-21Initiated Goldman Neutral $5
Aug-31-17Resumed BTIG Research Buy $12
Nov-04-15Reiterated UBS Buy $25 → $26
Aug-11-15Initiated Jefferies Buy $30
Feb-04-15Reiterated UBS Buy $17 → $25
Dec-31-21 12:00PM  
Dec-15-21 08:30AM  
Nov-30-21 08:30AM  
Nov-24-21 06:56AM  
Nov-19-21 08:20AM  
Nov-15-21 08:15PM  
Nov-12-21 04:15PM  
Nov-08-21 04:05PM  
Oct-26-21 08:00AM  
Oct-25-21 03:01PM  
Oct-15-21 08:49AM  
Oct-14-21 08:45AM  
Oct-12-21 08:45AM  
Oct-05-21 07:45AM  
Oct-04-21 09:20AM  
Oct-01-21 04:55PM  
Sep-01-21 08:21AM  
Aug-26-21 10:06AM  
Aug-11-21 07:45AM  
Aug-05-21 06:30AM  
Aug-02-21 04:30PM  
Jul-29-21 08:30AM  
Jul-02-21 04:30PM  
Jun-10-21 09:32AM  
Jun-01-21 06:30AM  
May-31-21 08:00AM  
May-25-21 08:30AM  
May-24-21 08:00AM  
Apr-12-21 09:00AM  
Apr-05-21 04:05PM  
Mar-02-21 08:00AM  
Mar-01-21 10:54AM  
Feb-24-21 04:05PM  
Feb-23-21 06:20AM  
Feb-16-21 01:27PM  
Feb-12-21 09:00AM  
Feb-01-21 07:30AM  
Jan-25-21 12:30PM  
Jan-19-21 08:00AM  
Jan-12-21 09:10AM  
Jan-08-21 05:42AM  
Dec-22-20 04:05PM  
Dec-10-20 08:30AM  
Nov-30-20 04:05PM  
Nov-09-20 04:05PM  
Nov-04-20 10:05AM  
Nov-02-20 08:27AM  
Oct-29-20 12:57PM  
Oct-26-20 12:31PM  
Oct-19-20 08:48AM  
Sep-28-20 07:00AM  
Sep-19-20 07:00AM  
Sep-16-20 11:07AM  
Sep-15-20 04:05PM  
Sep-14-20 03:37PM  
Sep-10-20 08:42PM  
Sep-09-20 04:05PM  
Sep-08-20 06:15AM  
Aug-27-20 08:30AM  
Aug-04-20 09:15AM  
Aug-03-20 07:48AM  
Jul-28-20 10:49AM  
Jul-23-20 08:30AM  
Jul-20-20 10:09PM  
Jul-17-20 08:00AM  
Jul-01-20 08:00AM  
Jun-22-20 10:35AM  
Jun-11-20 10:21AM  
Jun-09-20 07:17AM  
May-26-20 04:30PM  
May-19-20 12:30PM  
May-11-20 02:00AM  
May-01-20 09:00AM  
Apr-27-20 04:05PM  
Apr-21-20 04:05PM  
Apr-06-20 08:00AM  
Mar-15-20 09:47AM  
Mar-13-20 04:30PM  
Feb-24-20 04:05PM  
Feb-14-20 08:04AM  
Feb-05-20 12:49AM  
Feb-04-20 10:08AM  
Feb-03-20 06:33AM  
Jan-30-20 07:30AM  
Jan-23-20 12:31PM  
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company also offers MosaiQ COVID-19 Microarray that is designed as a serological disease screening microarray specific to COVID-19 antibody detection. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
El Khoury MohammadChief Commercial OfficerDec 16Buy2.0550,000102,50050,000Dec 17 06:48 PM
Stackawitz JeremyChief Commercial OfficerFeb 04Sale5.1430,000154,197112,926Feb 08 04:05 PM
Farrell EdwardChief Operating Officer (+)Feb 03Sale5.0796,000487,05629,757Feb 05 04:20 PM